Paul Anaya is a Cardiology physician affiliated with University of Kentucky. OpenAlex indexes 40 publications with 526 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Gill Heart Institute 800 Rose St
G100
Lexington, KY 405360093
Telephone
859-323-0295Registry record last updated 23 Aug 2017.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20251 payment
- Abbott LaboratoriesProgram year20251 payment
- Abbott LaboratoriesProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.2%Beta blocker17.5%Carvedilol46%Metoprolol Succinate46%Metoprolol Tartrate8%Part D<11 patientsStatin14.7%Atorvastatin Calcium60%Rosuvastatin Calcium40%Part D≥37 patients+ 10 more classes in this area
Blood & clotting
15.2%Factor Xa inhibitor12.4%Eliquis92%Xarelto8%Part D<11 patientsVitamin K antagonist1.7%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
9.6%SGLT2 inhibitor6.7%Jardiance85%Farxiga15%Part D<11 patientsProton pump inhibitor1.8%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Spatial control of myosin regulatory light chain phosphorylation modulates cardiac thick filament mechanosensing
Proceedings of the National Academy of Sciences
2026 - Rapid Buprenorphine Initiations for Cardiac Emergencies in Patients on High-dose Methadone: A Case Report
Journal of Addiction Medicine
2025 - Spatial control of myosin regulatory light chain phosphorylation modulates cardiac thick filament mechano-sensing
bioRxiv (Cold Spring Harbor Laboratory)
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David Moliterno, MD
University of Kentucky
Robert Dipaola
University of Kentucky
Darwin Conwell, MD
University of Kentucky
Phillip Tibbs
University of Kentucky
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”